RS56243B1 - Jedinjenje dikarboksilne kiseline - Google Patents
Jedinjenje dikarboksilne kiselineInfo
- Publication number
- RS56243B1 RS56243B1 RS20170851A RSP20170851A RS56243B1 RS 56243 B1 RS56243 B1 RS 56243B1 RS 20170851 A RS20170851 A RS 20170851A RS P20170851 A RSP20170851 A RS P20170851A RS 56243 B1 RS56243 B1 RS 56243B1
- Authority
- RS
- Serbia
- Prior art keywords
- dicarboxylic acid
- acid compound
- compound
- dicarboxylic
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013091090 | 2013-04-24 | ||
EP14787530.6A EP2990400B1 (en) | 2013-04-24 | 2014-04-23 | Dicarboxylic acid compound |
PCT/JP2014/061390 WO2014175317A1 (ja) | 2013-04-24 | 2014-04-23 | ジカルボン酸化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
RS56243B1 true RS56243B1 (sr) | 2017-11-30 |
Family
ID=51791887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20170851A RS56243B1 (sr) | 2013-04-24 | 2014-04-23 | Jedinjenje dikarboksilne kiseline |
Country Status (28)
Country | Link |
---|---|
US (2) | US9617232B2 (sr) |
EP (1) | EP2990400B1 (sr) |
JP (1) | JP5774253B2 (sr) |
KR (1) | KR102168259B1 (sr) |
CN (3) | CN107311895A (sr) |
AU (1) | AU2014258419B2 (sr) |
BR (1) | BR112015026840A2 (sr) |
CA (1) | CA2909400C (sr) |
CY (1) | CY1119296T1 (sr) |
DK (1) | DK2990400T3 (sr) |
ES (1) | ES2640802T3 (sr) |
HK (1) | HK1222385A1 (sr) |
HR (1) | HRP20171273T1 (sr) |
HU (1) | HUE034554T2 (sr) |
IL (1) | IL242195B (sr) |
LT (1) | LT2990400T (sr) |
MX (1) | MX2015014921A (sr) |
MY (1) | MY170262A (sr) |
NZ (1) | NZ712660A (sr) |
PH (1) | PH12015502429A1 (sr) |
PL (1) | PL2990400T3 (sr) |
PT (1) | PT2990400T (sr) |
RS (1) | RS56243B1 (sr) |
RU (1) | RU2662817C2 (sr) |
SG (1) | SG11201508542SA (sr) |
SI (1) | SI2990400T1 (sr) |
TW (1) | TWI594975B (sr) |
WO (1) | WO2014175317A1 (sr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI594975B (zh) * | 2013-04-24 | 2017-08-11 | 第一三共股份有限公司 | 二羧酸化合物 |
CA2962724C (en) * | 2014-09-26 | 2019-11-19 | Daiichi Sankyo Company, Limited | Salt of dicarboxylic acid compound |
TW201700458A (zh) * | 2015-04-24 | 2017-01-01 | 第一三共股份有限公司 | 二羧酸化合物之製法 |
EP3700934A4 (en) | 2017-10-24 | 2021-10-27 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THESE COMPOUNDS |
BR112020019191A2 (pt) * | 2018-03-23 | 2021-01-05 | Yumanity Therapeutics, Inc. | Compostos e seus usos |
WO2023219127A1 (ja) * | 2022-05-11 | 2023-11-16 | 中外製薬株式会社 | 嚢胞性疾患を治療または予防するための医薬組成物 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ231939A (en) | 1988-12-28 | 1991-07-26 | Takeda Chemical Industries Ltd | Benzothiopyran derivatives and medicaments |
DD280329A1 (de) * | 1989-03-09 | 1990-07-04 | Bitterfeld Chemie | Dispersionsfarbstoffpraeparate zum faerben und bedrucken von polyestermaterialien i |
TW575563B (en) * | 1997-08-19 | 2004-02-11 | American Cyanamid Co | Process for the preparation of pyridyl carboxylic amides and esters |
AU2002354410A1 (en) * | 2001-12-05 | 2003-06-17 | Japan Tobacco Inc. | Triazole compound and medicinal use thereof |
AU2003265382A1 (en) * | 2002-08-23 | 2004-03-11 | Pharmacia & Upjohn Company Llc | Antibacterial benzoic acid derivatives |
US8134015B2 (en) * | 2003-03-27 | 2012-03-13 | Kyowa Hakko Kirin Co., Ltd. | Compound inhibiting in vivo phosphorous transport and medicine containing the same |
FR2872159B1 (fr) | 2004-06-28 | 2007-10-05 | Merck Sante Soc Par Actions Si | Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete |
NZ588983A (en) * | 2008-06-25 | 2011-11-25 | Daiichi Sankyo Co Ltd | Carboxylic acid compound |
PE20120345A1 (es) | 2009-05-26 | 2012-05-17 | Abbvie Bahamas Ltd | Derivados de 2-(1h-pirrolo[2,3-b]piridin-5-iloxi)-n-fenilsulfonilbenzamida como inhibidores de proteinas anti-apoptoticas |
DE102009046115A1 (de) * | 2009-10-28 | 2011-09-08 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 3-Phenylpropansäuren und ihre Verwendung |
SG184497A1 (en) | 2010-04-12 | 2012-11-29 | Somalogic Inc | 5-position modified pyrimidines and their use |
EP2565190B1 (en) * | 2010-04-28 | 2015-06-03 | Astellas Pharma Inc. | Tetrahydrobenzothiophene compound |
EP2591354B1 (en) * | 2010-07-07 | 2016-09-07 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
WO2012054110A2 (en) * | 2010-07-07 | 2012-04-26 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
IN2014CN03130A (sr) * | 2011-10-27 | 2015-07-03 | Astellas Pharma Inc | |
WO2013082756A1 (en) * | 2011-12-06 | 2013-06-13 | Leo Pharma A/S | Phosphate transport inhibitors ii |
WO2013082751A1 (en) * | 2011-12-06 | 2013-06-13 | Leo Pharma A/S | Phosphate transport inhibitors i |
WO2014003153A1 (ja) | 2012-06-28 | 2014-01-03 | 協和発酵キリン株式会社 | 置換アミド化合物 |
TWI594975B (zh) * | 2013-04-24 | 2017-08-11 | 第一三共股份有限公司 | 二羧酸化合物 |
CA2962724C (en) * | 2014-09-26 | 2019-11-19 | Daiichi Sankyo Company, Limited | Salt of dicarboxylic acid compound |
-
2014
- 2014-04-21 TW TW103114341A patent/TWI594975B/zh not_active IP Right Cessation
- 2014-04-23 NZ NZ71266014A patent/NZ712660A/en not_active IP Right Cessation
- 2014-04-23 RS RS20170851A patent/RS56243B1/sr unknown
- 2014-04-23 CA CA2909400A patent/CA2909400C/en not_active Expired - Fee Related
- 2014-04-23 EP EP14787530.6A patent/EP2990400B1/en active Active
- 2014-04-23 CN CN201710600754.4A patent/CN107311895A/zh active Pending
- 2014-04-23 AU AU2014258419A patent/AU2014258419B2/en not_active Ceased
- 2014-04-23 KR KR1020157027428A patent/KR102168259B1/ko active IP Right Grant
- 2014-04-23 RU RU2015150120A patent/RU2662817C2/ru active
- 2014-04-23 ES ES14787530.6T patent/ES2640802T3/es active Active
- 2014-04-23 PT PT147875306T patent/PT2990400T/pt unknown
- 2014-04-23 MY MYPI2015002483A patent/MY170262A/en unknown
- 2014-04-23 HU HUE14787530A patent/HUE034554T2/en unknown
- 2014-04-23 CN CN201710600302.6A patent/CN107337621A/zh active Pending
- 2014-04-23 US US14/784,187 patent/US9617232B2/en active Active
- 2014-04-23 DK DK14787530.6T patent/DK2990400T3/da active
- 2014-04-23 MX MX2015014921A patent/MX2015014921A/es unknown
- 2014-04-23 WO PCT/JP2014/061390 patent/WO2014175317A1/ja active Application Filing
- 2014-04-23 CN CN201480022830.2A patent/CN105121405A/zh active Pending
- 2014-04-23 SI SI201430269T patent/SI2990400T1/sl unknown
- 2014-04-23 LT LTEP14787530.6T patent/LT2990400T/lt unknown
- 2014-04-23 SG SG11201508542SA patent/SG11201508542SA/en unknown
- 2014-04-23 PL PL14787530T patent/PL2990400T3/pl unknown
- 2014-04-23 BR BR112015026840A patent/BR112015026840A2/pt not_active Application Discontinuation
- 2014-04-23 JP JP2015513789A patent/JP5774253B2/ja active Active
-
2015
- 2015-10-21 PH PH12015502429A patent/PH12015502429A1/en unknown
- 2015-10-21 IL IL242195A patent/IL242195B/en active IP Right Grant
-
2016
- 2016-09-02 HK HK16110460.2A patent/HK1222385A1/zh not_active IP Right Cessation
- 2016-09-30 US US15/282,384 patent/US9670173B2/en active Active
-
2017
- 2017-08-22 HR HRP20171273TT patent/HRP20171273T1/hr unknown
- 2017-09-06 CY CY20171100944T patent/CY1119296T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL240602A0 (en) | A compound that inhibits trk | |
EP3919505C0 (en) | USES OF CAS9 NUCLEIC ACID COMPLEXES | |
GB201311891D0 (en) | Novel compound | |
HK1222393A1 (zh) | 新的喹啉取代的化合物 | |
GB201302368D0 (en) | Compound | |
ME03398B (me) | Spojevi dimetilbenzojeve kiseline | |
HRP20181371T1 (hr) | Spoj estera gvanidinbenzojeve kiseline | |
HK1222385A1 (zh) | 二羧酸化合物 | |
HK1219100A1 (zh) | 吡啶基吡唑並喹啉化合物 | |
EP2947066A4 (en) | PHENOXYALKYLAMINVERBINDUNG | |
GB201303158D0 (en) | Ritalinic Acid Immunoassay | |
GB201307331D0 (en) | Compound | |
GB201408643D0 (en) | Compound | |
GB201322438D0 (en) | Compound | |
GB201315772D0 (en) | Compound | |
GB201305634D0 (en) | Compound | |
GB201304250D0 (en) | Compound | |
GB201301585D0 (en) | Compound |